One of multiple genetic risk variants identified in these studies is the rare p.Arg47His (R47H) variant within triggering receptor expressed on myeloid cells 2 (TREM2), which has been shown to increase the risk of developing AD by 2–3-fold in several European and North American populations [19,20,21,22,23,24]. Here, TREM2 is linked to Alzheimer disease.